Brief: Xilio Therapeutics Appoints Stacey Davis As Chief Business Officer
17/05/2022 12:43
Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS APPOINTS STACEY DAVIS AS CHIEF BUSINESS
OFFICER
Source text for Eikon: ID:nGNX9L94QV
Further company coverage: XLO.O
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla